Brian Dragan
Chiropractor · Glen Burnie, MDNPI 1376544304
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 42 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 16 manufacturers, the largest accounting for just 18.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $327 and has fallen 91.4% since, to $28 in 2025. Among chiropractor clinicians in MD with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 42 payments — averaging $19.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$147
- Ironshore Pharmaceuticals Inc.$99
- Otsuka America Pharmaceutical, Inc.$95
- AstraZeneca$94
- AbbVie$73
- Novo Nordisk$62
- plus $234 from 10 others
What the payments were for
- Food & beverage$805100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 8 | $147 |
| Ironshore Pharmaceuticals Inc. | 4 | $99 |
| Otsuka America Pharmaceutical, Inc. | 5 | $95 |
| AstraZeneca | 5 | $94 |
| AbbVie | 4 | $73 |
| Novo Nordisk | 3 | $62 |
| Merck | 3 | $46 |
| Boehringer Ingelheim | 2 | $41 |
| Pfizer | 1 | $24 |
| Amarin Pharma, Inc. | 1 | $22 |
| Vanda Pharmaceuticals Inc. | 1 | $22 |
| Nevro Corp. | 1 | $17 |
| Gilead | 1 | $16 |
| Lilly USA, LLC | 1 | $16 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
How this compares
$805 in reported general payments places this provider in the 90th percentile of 71 chiropractor providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other chiropractor in Glen Burnie
- Amy RecceGlen Burnie$2K
- Arash YousefiGlen Burnie$72
- Douglas MillerBaltimore$3K
- Brian ParisRockville$1K
- Arash SarabiRockville$1K
- Steven MahoneyColumbia$800
- William FullmerSilver Spring$493
- Mohammad YousefiSilver Spring$402
- Warren KalksteinTowson$246
- Xin MiaoRockville$230
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.